Significant improvements in functional ability and QoL were reported in “De-novo” and in “L-dopa” (treatment-refractory tremor) cohorts following the first injection, with an observed trend of tremor reduction being on average 14.1% greater in the “L-dopa” cohort over the treatment course (weeks 6–42).
← all excerpts
Standardized algorithm for muscle selection and dosing of botulinum toxin for Parkinson tremor using kinematic analysis.
1
—
—